|
1
|
Ramakrishna N, Temin S, Chandarlapaty S,
Crews JR, Davidson NE, Esteva FJ, Giordano SH, Gonzalez-Angulo AM,
Kirshner J, Krop I, et al: Recommendations on disease management
for patients with advanced human epidermal growth factor receptor
2-positive breast cancer and brain metastases: American society of
clinical oncology clinical practice guideline. J Clin Oncol.
32:2100–2108. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Subramanian S and Keating NL: Delays in
breast cancer diagnosis after a state policy limiting medicaid
enrollment. Cancer. 123:3219–3221. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Tu Z, Xiao R, Xiong J, Tembo KM, Deng X,
Xiong M, Liu P, Wang M and Zhang Q: CCR9 in cancer: Oncogenic role
and therapeutic targeting. J Hematol Oncol. 9(10)2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Bidard FC, Hajage D, Bachelot T, Delaloge
S, Brain E, Campone M, Cottu P, Beuzeboc P, Rolland E, Mathiot C
and Pierga JY: Assessment of circulating tumor cells and serum
markers for progression-free survival prediction in metastatic
breast cancer: A prospective observational study. Breast Cancer
Res. 14(R29)2012.PubMed/NCBI View
Article : Google Scholar
|
|
5
|
Edge SB and Compton CC: The American joint
committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474.
2010.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lakhani SR, Ellis IO, Schnitt SJ, Tan
PH and van de Vijver MJ (eds): WHO Classification of Tumours of
the Breast. IARC Press, Lyon, France, 2012.
|
|
7
|
Kim GR, Choi JS, Han BK, Ko EY, Ko ES and
Hahn SY: Combination of shear-wave elastography and color Doppler:
Feasible method to avoid unnecessary breast excision of
fibroepithelial lesions diagnosed by core needle biopsy. PLoS One.
12(e0175380)2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lee SH, Chang JM, Cho N, Yi A, Choi SH,
Kook SH, Youk JH, Son EJ, Chung J, Cha ES, et al: Abstract
P5-02-02: Combined use of elastography and color doppler ultrasound
for the evaluation of breast masses detected at screening
ultrasound in women with dense breasts. Cancer Res. 77(P5)2017.
|
|
9
|
Printzcancer C: Breast cancer mortality
rates decline internationally, with some major exceptions. Cancer.
123(1085)2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zaleska-Dorobisz U, Kaczorowski K, Pawluś
A, Puchalska A and Inglot M: Ultrasound elastography-review of
techniques and its clinical applications. Adv Clin Exp Med.
23:645–655. 2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sprague BL, Stout NK, Schechter C, van
Ravesteyn NT, Cevik M, Alagoz O, Lee CI, van den Broek JJ,
Miglioretti DL, Mandelblatt JS, et al: Benefits, harms, and
costeffectiveness of supplemental ultrasonography screening for
women with dense breasts. Ann Intern Med. 162:157–166.
2015.PubMed/NCBI View
Article : Google Scholar
|
|
12
|
Chae EY, Moon WK, Kim HH, Kim WH, Cha JH,
Shin HJ, Choi WJ, Han W, Noh DY, Lee SB and Ahn SH: Association
between ultrasound features and the 21-gene recurrence score assays
in patients with oestrogen receptor-positive,HER2-negative,invasive
breast cancer. PLoS One. 11(e0158461)2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Costantini M, Belli P, Lombardi R,
Franceschini G, Mulè A and Bonomo L: Characterization of solid
breast masses: Use of the sonographic breast imaging reporting
anddata system lexicon. J Ultrasound Med. 25:649–659.
2006.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Bae MS, Seo M, Kim KG, Park IA and Moon
WK: Quantitative MRI morphology of invasive breast cancer:
Correlation with immunohistochemical biomarkers and subtypes. Acta
Radiol. 56:269–275. 2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ma Y, Li G, Li J and Ren WD: The
diagnostic value of superb microvascular imaging (SMI) in detecting
blood flow signals of breast lesions: A preliminary study comparing
smi to color doppler flow imaging. Medicine (Baltimore).
94(e1502)2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Xu MG, Xu JK, Huang HQ and Zhang B: The
significance of her 2 gene detection in breast cancer diagnosis and
treatment. Mod Oncol. 23:2701–2705. 2015.
|
|
17
|
Bahrami A, Mortazavizadeh MR, Yazdi MF and
Chamani M: Serial tumor markers serum carcinoembryonic antigenand
cancer antigen 153 assays in detecting symptomatic metastasis in
breast cancer patients. East Mediterr Health J. 18:1055–1059.
2012.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Duffy MJ, Evoy D and McDermott EW: CA15-3:
Uses and limitation as a biomarker for breast cancer. Clin Chim
Acta. 411:1869–1874. 2010.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Svobodova S, Kucera R, Fiala O, Karlikova
M, Narsanska A, Zedníková I, Treska V, Slouka D, Rousarova M,
Topolcan O and Finek J: CEA, CA15-3 and TPS as prognostic factors
in the follow-up monitoring of patients after radical surgery for
breast cancer. Anticancer Res. 38:465–469. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Brooks M: Breast cancer screening and
biomarkers. Methods Mol Biol. 472:307–321. 2009.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wang G, Qin Y, Zhang J, Zhao J, Liang Y,
Zhang Z, Qin M and Sun Y: Nipple discharge of CA15-3, CA125, CEA
and TSGF as a new biomarker panel for breast cancer. Int J Mol Sci.
28:9546–9565. 2014.PubMed/NCBI View Article : Google Scholar
|
